-
MiR-124-3p/EIF3B regulates host cell apoptosis induced by Chlamydia psittaci through PI3K/AKT signaling pathway J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-19 Ting Tong, Yunfei Li, You Zhou, Xindian Zeng, Cui Xiao, Saihong Cao, Chuan Wang, Zhongyu Li, Zhou zhou, Qinqin Bai, Shenghua Chen, Shuwu Yan, Lili Chen
Chlamydia psittaci is a zoonotic pathogen known to cause respiratory diseases in humans. Chlamydia infections are closely associated with apoptosis, in which miRNAs play regulatory roles. Herein, we demonstrated that C. psittaci infection induces apoptosis in human bronchial epithelial (HBE) cells and investigated regulatory mechanism involving miR-124-3p and the PI3K/AKT signaling pathway. Following
-
Compartmentalized HIV-1 reservoir in intestinal monocytes/macrophages on antiretroviral therapy J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-19 Camille Vellas, Dorine Martres, Mary Requena, Manon Nayrac, Nived Collercandy, Justine Latour, Karl Barange, Laurent Alric, Guillaume Martin-Blondel, Jacques Izopet, Bernard Lagane, Pierre Delobel
Background The persistence of latently infected cells prevents a cure of HIV. The intestinal mucosa contains numerous target cells, and high levels of HIV-1 DNA persist in this compartment under ART. While CD4+ T cells are the best characterized reservoir of HIV-1, the role of long-lived intestinal macrophages in HIV-1 persistence on ART remains controversial. Methods We collected duodenal and colonic
-
FGF8 protects against polymicrobial sepsis by enhancing the host's anti-infective immunity J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-18 Kai Chen, Yanting Ruan, Wenjing Ma, Xiaoyan Yu, Ying Hu, Yue Li, Hong Tang, Xuemei Zhang, Yibing Yin, Dapeng Chen, Zhixin Song
Background Sepsis is characterized by a life-threatening syndrome caused by an unbalanced host response to infection. Fibroblast Growth Factor 8 (FGF8) has been newly identified to play important roles in inflammation and innate immunity, but its role in host response to sepsis is undefined. Methods A cecal ligation and puncture (CLP) -induced mouse sepsis model was established to evaluate the immunomodulatory
-
Annual Clinical and Economic Burden of Medically Attended Lower Respiratory Tract Illnesses Due to Respiratory Syncytial Virus among US Infants Aged <12 Months J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-15 Linnea Houde, Amy W Law, Ahuva Averin, Derek Weycker, Alejandro Cane, Sarah Pugh, Kimberly M Shea
We developed a model to project the expected annual clinical and economic burden of medically attended lower respiratory tract illnesses due to respiratory syncytial virus (RSV-LRTI) among US infants aged <12 months by combining information on population size, disease rates, mortality rates, and unit costs. Among the 3.7 million US infants aged <12 months each year, a total of 592,700 cases of RSV-LRTI
-
A potential platform for future vaccine trials identifies high incidence of symptomatic and asymptomatic influenza infection among children aged 6-23 months in South Africa J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-15 Cheryl Cohen, Mignon du Plessis, Neil Martinson, Jocelyn Moyes, Sibongile Walaza, Nicole Wolter, Mvuyo Makhasi, Fahima Moosa, Myrna Charles, Aaron M Samuels, Stefano Tempia, Tumelo Moloantoa, Bekiwe Ncwana, Louisa Phalatse, Amelia Buys, Alicia Fry, Eduardo Azziz Baumgartner, Anne von Gottberg, Jackie Kleynhans
Background Approaches for determining whether influenza vaccination prevents infection, attenuates illness, or both, are important for developing improved vaccines. We estimated influenza infection incidence, and evaluated symptom ascertainment methodologies in children to inform future vaccine trial design. Methods We conducted a prospective cohort study among children aged 6-23 months from May-October
-
Mycobacterium tuberculosis Antigen Rv1471 Induces Innate Immune Memory and Adaptive Immunity against Infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-14 Xuejiao Huang, Juan Wu, Jinchuan Xu, Huiling Wang, Zhenyan Chen, Xiao-Yong Fan, Zhidong Hu
Protein subunit vaccines form a key pipeline for developing novel tuberculosis (TB) vaccines. Mycobacterium tuberculosis (Mtb) contains approximately 4000 individual proteins. However, only approximately 100 have been evaluated as antigens in the clinical and preclinical stages of vaccine development. Trained immunity-targeting vaccines induce innate immune memory against heterologous infections and
-
Real-World Application of the MeMed BV Test in Differentiating Bacterial, Viral, and Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia. J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-13 Marco Denina,Carlo Maria Minero,Raffaele Vitale,Cecilia Maria Pini,Matteo Operti,Silvia Garazzino,Claudia Bondone
-
Epidemiologic and genomic characterization of an outbreak of Rift Valley fever among humans and dairy cattle in northern Tanzania J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-13 Deng B Madut, Matthew P Rubach, Kathryn J Allan, Kate M Thomas, William A de Glanville, Jo E B Halliday, Cristina Costales, Manuela Carugati, Robert J Rolfe, John P Bonnewell, Michael J Maze, Alex R Mremi, Patrick T Amsi, Nathaniel H Kalengo, Furaha Lyamuya, Grace D Kinabo, Ronald Mbwasi, Kajiru G Kilonzo, Venance P Maro, Blandina T Mmbaga, Bingileki Lwezaula, Calvin Mosha, Annette Marandu, Tito J
Background A peri-urban outbreak of Rift Valley fever virus (RVFV) among dairy cattle from May through August 2018 in northern Tanzania was detected through testing samples from prospective livestock abortion surveillance. We sought to identify concurrent human infections, their phylogeny, and epidemiologic characteristics in a cohort of febrile patients enrolled from 2016-2019 at hospitals serving
-
An antimicrobial blue light prototype device controls infected wounds in a preclinical porcine model J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-13 Laisa Bonafim Negri, William Farinelli, Sandeep Korupolu, Ying Wang, Yara Mannaa, Hang Lee, Jie Hui, Pu-Ting Dong, Andrea Slate, Joshua Tam, R Rox Anderson, Seok-Hyun Andy Yun, Jeffrey A Gelfand
We developed a translational prototype antimicrobial blue light (ABL) device for treating skin wounds with ABL. Partial-thickness surgical wounds were created in live swine, an animal whose skin is considered the most like human skin, then heavily contaminated and left untreated for 24 hours with methicillin-resistant Staphylococcus aureus (MRSA). ABL treatment stabilized and reduced MRSA infection
-
Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions following SARS-CoV-2 infection in a US prospective cohort of essential workers J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-12 Josephine Mak, Sana Khan, Amadea Britton, Spencer Rose, Lisa Gwynn, Katherine D Ellingson, Jennifer Meece, Leora Feldstein, Harmony Tyner, Laura Edwards, Matthew S Thiese, Allison Naleway, Manjusha Gaglani, Natasha Solle, Jefferey L Burgess, Julie Mayo Lamberte, Meghan Shea, Taryn Hunt-Smith, Alberto Caban-Martinez, Cynthia Porter, Ryan Wiegand, Ramona Rai, Kurt T Hegmann, James Hollister, Ashley Fowlkes
Background While there is evidence that COVID-19 vaccination protects against development of post-COVID conditions (PCC) after severe infection data are limited on whether vaccination reduces the risk after cases of less-severe non-hospitalized COVID-19 disease with more recent SARS-CoV-2 variant viruses. This study assessed whether COVID-19 vaccination was protective against subsequent development
-
Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-12 Gustaf Ulfhammer, Aylin Yilmaz, Åsa Mellgren, Erika Tyrberg, Erik Sörstedt, Lars Hagberg, Johanna Gostner, Dietmar Fuchs, Henrik Zetterberg, Staffan Nilsson, Kristina Nyström, Arvid Edén, Magnus Gisslén
Background The incidence and clinical relevance of asymptomatic cerebrospinal fluid escape (CSF-E) during antiretroviral therapy (ART) is uncertain. We examined the impact and incidence of asymptomatic CSF-E in a Swedish HIV cohort. Methods Neuroasymptomatic people living with HIV (PLWH) who have been on ART for at least six months with suppressed plasma viral load were followed longitudinally. CSF-E
-
Fitness of SARS-CoV-2 Omicron subvariants in respiratory and gastrointestinal cell lines as determined by RT-ddPCR and whole genome sequencing J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-09 Mathilde Hénaut, Julie Carbonneau, Inès Levade, Guy Boivin
The fitness of SARS-CoV-2 Omicron subvariants was determined in human epithelial and continuous cells of the respiratory and gastrointestinal tracts. Competition experiments over 4 days were performed followed by quantification of variant ratios by reverse transcription-droplet digital PCR. These quantitative data were correlated with whole genome sequencing. In competition experiments of two subvariants
-
Lower levels of household transmission of SARS-CoV-2 VOC Omicron compared to Wild-type: an interplay between transmissibility and immune status J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-08 A M A M Winkel, E Kozanli, M E Haverkort, S M Euser, J G C Sluiter-Post, R Mariman, A Vogelzang, J de Bakker, C R Lap, M A van Houten, D Eggink, S F L van Lelyveld
Background Knowledge of SARS-CoV-2 household transmission dynamics guides infection control and vaccination measures. This household cohort study prospectively assessed the impact of both the Omicron BA.2 variant and immunity on household transmission using dense saliva sampling and sequence analysis. Methods Households consisting of a PCR-confirmed index and at least two household members were enrolled
-
Early Viral Dynamics Predict HIV Post-Treatment Control After Analytic Treatment Interruption J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-08 Gesham Magombedze, Elena Vendrame, Devi SenGupta, Romas Geleziunas, Susan Little, Davey Smith, Bruce Walker, Jean-Pierre Routy, Frederick M Hecht, Tae-Wook Chun, Michael Sneller, Jonathan Z Li, Steven G Deeks, Michael J Peluso
Background A key research priority for developing an HIV cure strategy is to define the viral dynamics and biomarkers associated with sustained post-treatment control. The ability to predict the likelihood of sustained post-treatment control or non-control could minimize the time off antiretroviral therapy (ART) for those destined to not control and anticipate longer periods off ART for those destined
-
2-[18F]F-p-aminobenzoic acid specifically detects infective endocarditis in positron emission tomography J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-08 Johannes Schulte, Andreas Maurer, Lisa-Charlotte Domogalla, Nils Steinacker, Carolin Wadle, Johannes Kinzler, Matthias Eder, Constantin von zur Mühlen, Marvin Krohn-Grimberghe, Ann-Christin Eder
Background To the present day infective endocarditis (IE) represents a life-threatening disease with high mortality rate especially when caused by Staphylococcus aureus (S. aureus), the most common causative pathogen in this disease. Diagnosis of IE is based on clinical manifestations, pathogen detection by blood cultures and echocardiographic or other imaging findings. However, none of the methods
-
At the mercy of the AI algorithm – discrepant PCR results J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-07 Mark Zuckerman, Temi Lampejo, Melvyn Smith
As pathogen molecular diagnostics technology develops, the software analysis of polymerase chain reaction (PCR) sigmoidal curves, crossing threshold (Ct) values and the limit of nucleic acid detection for that assay, is not always available when reporting test results. These are critical components in interpreting results and can affect the management of patients. Our view is that all commercial assay
-
Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited by Inactivated and Live Attenuated Vaccines in Children J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-06 Sergey Yegorov, Angela Brewer, Louis Cyr, Brian J Ward, Eleanor Pullenayegum, Matthew S Miller, Mark Loeb
Background Hemagglutinin (HA)-inhibiting antibodies contribute to the immune defense against influenza infection. However, there are insufficient data on the extent of correlation between vaccine-elicited HA antibodies and protection in children against different influenza strains, particularly when comparing live attenuated influenza vaccines (LAIV) versus inactivated influenza vaccines (IIV). Methods
-
Detection of live attenuated measles virus in the respiratory tract following subcutaneous MMR Vaccination J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-06 Timothy A Watkins, Jacqueline K Brockhurst, Gregory Germain, Diane E Griffin, Ellen F Foxman
The live attenuated measles vaccine is extremely effective in preventing measles and induces mucosal immunity in the respiratory tract, however the mechanism is not known. We show that live attenuated measles virus (LAMV) RNA is frequently detected in the respiratory tract 7-21 days after subcutaneous measles-mumps-rubella (MMR) vaccination in healthy children (n = 5/20) and macaques (n = 6/8). Replicating
-
The ABCDs of nutritional assessment in infectious diseases research J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-06 Lindsey M Locks, Aneri Parekh, Katharine Newell, Madolyn R Dauphinais, Chelsie Cintron, Kimberly Maloomian, Elaine A Yu, Julia L Finkelstein, Saurabh Mehta, Pranay Sinha
Malnutrition is the most common acquired cause of immunodeficiency worldwide. Nutritional deficiencies can blunt both the innate and adaptive immune response to pathogens. Furthermore, malnutrition is both a cause and consequence of infectious diseases. The bidirectional relationship between infectious diseases and undernutrition, as well as the inflammatory milieu of infectious diseases, can complicate
-
Development of a rapid, culture-free, universal microbial identification system using internal transcribed spacer targeting primers J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-06 Vishwaratn Asthana, Erika Martínez Nieves, Pallavi Bugga, Clara Smith, Tim Dunn, Satish Narayanasamy, Robert P Dickson, J Scott VanEpps
The indiscriminate administration of broad-spectrum antibiotics is a primary contributor to the increasing prevalence of antibiotic resistance. Unfortunately, culture, the gold standard for bacterial identification is a time intensive process. Due to this extended diagnostic period, broad-spectrum antibiotics are generally prescribed to prevent poor outcomes. To overcome the deficits of culture-based
-
Fecal and Sputum Microbiota and Treatment Response in Patients with Mycobacterium abscessus Pulmonary Disease J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-05 Joong-Yub Kim, Sujin An, So Yeon Kim, Eunhye Bae, Yong-Joon Cho, Nakwon Kwak, Donghyun Kim, Jae-Joon Yim
Background The microbiota is a potential source of biomarkers for clinical outcomes in chronic respiratory conditions, but its role in Mycobacterium abscessus pulmonary disease (PD) remains unexplored. We aimed to identify microbial signatures in fecal and sputum microbiotas associated with treatment response in patients with M. abscessus PD. Methods We conducted a cohort study prospectively enrolling
-
Obesity uncovers presence of inflammatory lung macrophage subsets with adipose tissue transcriptomic signature in influenza virus infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-01 Pablo C Alarcon, Cassidy J Ulanowicz, Michelle S M A Damen, John Eom, Keisuke Sawada, Hak Chung, Tara Alahakoon, Jarren R Oates, Jennifer L Wayland, Traci E Stankiewicz, Maria E Moreno-Fernandez, William J Zacharias, Nathan Salomonis, Senad Divanovic
Obesity is a risk factor for increased lung damage and disease severity during influenza virus infection. White adipose tissue (WAT) inflammation is a key driver of disease pathogenesis in obesity. Whether and how obesity modifies lung and WAT immune cell character and function in obesity to amplify influenza disease severity remains unknown. We show that obesity establishes a proinflammatory transcriptome
-
The vaginal microbiome, setting the stage for cancer? J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-01 Ryan S Doster
-
Immunometabolic Contributions of Atopobiaceae Family Members in Human Papillomavirus Infection, Cervical Dysplasia and Cancer J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-01 Nicole R Jimenez, Vianney Mancilla, Paweł Łaniewski, Melissa M Herbst-Kralovetz
Background In the cervicovaginal environment, HPV acquisition and cervical cancer progression are linked to non-Lactobacillus dominance, of which Atopobiaceae are key taxa. We hypothesize that Atopobiaceae modulates the cervicovaginal microenvironment to promote HPV persistence and progression to cancer. However, the extent to which Atopobiaceae impact the immunometabolic microenvironment is poorly
-
Clinical characteristics and in-hospital outcomes associated with RSV-ALRI compared to other viral ALRI in hospitalised children under two years old J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-01 Acacia Ozturk, Mei Chan, Jahid Rahman Khan, Nan Hu, Brendan McMullan, Philip N Britton, Adam Bartlett, Rama Kandasamy, Gemma L Saravanos, Bernadette Prentice, Ting Shi, Adam Jaffe, Louisa Owens, Nusrat Homaira
Background Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRIs) associated hospitalisations in children. It is unclear if hospitalized RSV-ALRI differs in clinically from other viral ALRIs. We aimed to compare the disease impact of hospitalised RSV with other viral ALRI in children under 2 years. Methods We conducted a retrospective study using electronic
-
Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women with HIV J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-31 Nicole H Tobin, Sarah L Brooker, Fan Li, Robert W Coombs, Susan E Cohn, Laura Moran, Mey Leon, Nuntisa Chotirosniramit, Emilia Jalil, Unoda A Chakalisa, Kimberly K Scarsi, Carmen D Zorrilla, Catherine Godfrey, Grace M Aldrovandi
Background HIV-1 antiretroviral therapy (ART) alters hormonal contraceptive levels delivered via intravaginal ring (IVR) in a regimen specific manner. We explored the role of the IVR on vaginal microbial communities, vaginal short chain fatty acids (SCFAs), vaginal HIV shedding, and the effect of vaginal microbes on hormone concentrations in cisgender women with HIV (WWH). Methods Vaginal microbes
-
HBV RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue Withdrawal J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-31 Norah A Terrault, Richard Sterling, Anna S Lok, Marc G Ghany, Jordan J Feld, Gavin Cloherty, Abdus S Wahed, Xue Yang
Introduction Withdrawal of nucleos(t)ide analog (NA) therapy is associated with hepatitis B surface antigen (HBsAg) loss and sustained, off-therapy partial cure (normal ALT [≤30 U/L males, ≤20 U/L females) with HBV DNA <2000 IU/mL) but should be offered only to those most likely to benefit. HBVRNA may be useful for risk stratification. Methods The Hepatitis B Research Network Immune-Active Trial prospectively
-
Two mosquito salivary antigens demonstrate promise as biomarkers of recent exposure to P. falciparum infected mosquito bites J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-30 Sarah Lapidus, Morgan M Goheen, Mouhamad Sy, Awa B Deme, Ibrahima Mbaye Ndiaye, Younous Diedhiou, Amadou Moctar Mbaye, Kelly A Hagadorn, Seynabou Diouf Sene, Mariama Nicole Pouye, Laty Gaye Thiam, Aboubacar Ba, Noemi Guerra, Alassane Mbengue, Hamidah Raduwan, Jacqueline Gagnon, Inés Vigan-Womas, Sunil Parikh, Albert I Ko, Daouda Ndiaye, Erol Fikrig, Yu-Min Chuang, Amy K Bei
Background Measuring malaria transmission intensity using the traditional entomological inoculation rate is difficult. Antibody responses to mosquito salivary proteins like SG6 have been used as biomarkers of exposure to Anopheles mosquito bites. Here, we investigate four mosquito salivary proteins as potential biomarkers of human exposure to mosquitoes infected with P. falciparum: mosGILT, SAMSP1
-
High mortality rates among individuals misdiagnosed with tuberculosis: a matched retrospective cohort study of individuals diagnosed with tuberculosis in Brazil J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-29 Ryan R Thompson, Sun Kim, Daniele Maria Pelissari, Luiza Ohana Harada, José Nildo de Barros Silva Júnior, Patricia Bartholomay Oliveira, Marcia C Castro, Ted Cohen, Nicolas A Menzies
We conducted a matched retrospective cohort study comparing mortality among individuals receiving a false-positive tuberculosis diagnosis (n=3701) to individuals correctly diagnosed with TB (n=8595) in Brazil from 2007-2016. Over an average 5.4-year follow-up period, we estimated a mortality rate ratio of 1.95 (95% confidence interval: 1.80, 2.11) for individuals incorrectly diagnosed with TB compared
-
Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-28 Lucía Bailón, Maria C Puertas, Maria C García-Guerrero, Igor Moraes-Cardoso, Ester Aparicio, Yovaninna Alarcón-Soto, Angel Rivero, Elias P Rosen, Jacob D Estes, Julià Blanco, Alex Olvera, Beatriz Mothe, Javier Martinez-Picado, José Moltó
Objective To compare the effects of first-line antiretroviral treatment (ART) with dolutegravir plus lamivudine (DTG+3TC) versus DTG plus emtricitabine/tenofovir alafenamide (FTC/TAF) on the evolution of the HIV-1 reservoir and immune activation biomarkers in people with HIV (PWH). Methods DUALITY was a 48-week, single-center, randomized, open-label clinical trial in ART-naïve PWH. Participants were
-
Troglitazone reduces intracellular Mycobacterium tuberculosis survival via macrophage autophagy through LKB1-AMPKα signaling J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-25 Jing Bi, Qinglong Guo, Yaqi Gong, Xi Chen, Haojia Wu, Li Song, Yating Xu, Min Ou, Zhaoqin Wang, Jiean Chen, Chenran Jiang, Aimei Liu, Guobao Li, Guoliang Zhang
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb), results in significant morbidity and mortality worldwide. Host-directed therapy (HDT), including conventional drugs, is a promising anti-TB strategy that shows synergistic antibacterial effects when combined with anti-TB drugs. Here, the mycobactericidal effect of three anti-diabetic drugs was examined. Of these, only Troglitazone (Trog)
-
Elevated levels of PDGF-BB and VEGF are associated with a decreased risk of readmission or death in children with severe malarial anemia J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-25 Mary G Slaughter, Samina Bhumbra, Kagan A Mellencamp, Ruth Namazzi, Robert O Opoka, Chandy C John
Background Children with severe malarial anemia (SMA) typically have low in-hospital mortality but have a high risk of post-discharge readmission or death. We hypothesized that the dysregulation of hematopoiesis, vascular growth factors, and endothelial function that occurs in SMA might affect risk of readmission or death. Methods Plasma was obtained from children 18 months to 12 years old with SMA
-
CpG-adjuvanted virus-like particle vaccine induces protective immunity against Leishmania donovani infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-24 Keon-Woong Yoon, Ki Back Chu, Gi-Deok Eom, Jie Mao, Eun-Kyung Moon, Sung Soo Kim, Fu-Shi Quan
Visceral leishmaniasis (VL) poses a significant public health challenge due to the lack of an approved human vaccine. We attempted to enhance the efficacy of virus-like particle vaccines expressing the Leishmania donovani promastigote surface antigen (LdPSA-VLP) by adjuvanting with CpG oligodeoxynucleotide (CpG-ODN). Here, adjuvanted vaccine-induced immune responses and their efficacies in mice challenged
-
Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-24 Isabel Leroux-Roels, Azhar Alhatemi, Magalie Caubet, Fien De Boever, Bertrand de Wergifosse, Mohamed El Idrissi, Guilherme S Ferreira, Bart Jacobs, Axel Lambert, Sandra Morel, Charlotte Servais, Juan Pablo Yarzabal
Background This study investigated the safety, reactogenicity, and immunogenicity in healthy subjects of a Clostridioides difficile vaccine candidate with/without adjuvant, targeting toxins A and B. Methods In this first-in-human, phase 1, observer-blind study, subjects aged 18–45 years were randomized to receive F2 antigen (n = 10) or placebo (n = 10), and subjects aged 50–70 years to receive F2 antigen
-
An Expression Quantitative Trait Locus of Fc Gamma Receptor Genes is Associated with Anti-Malarial IgG Responses and Infection Levels in Burkinabe Families J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-23 Christelle Dieppois, Mathieu Adjemout, Jules Cretin, Frederic Gallardo, Magali Torres, Christophe Picard, Serge Aimé Sawadogo, Pascal Rihet, Pascale Paul
Background The interaction between antibodies and Fc gamma receptors (FcγRs) plays a critical role in regulating immune responses to Plasmodium falciparum. Polymorphisms in genes encoding FcγRs influence the host's capacity to control parasite infection. This study investigates whether non-coding variants influencing FcγR expression are associated with anti-malarial immunization and infection traits
-
EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial Virus. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-23 Rachel Emily Levene,John DeVincenzo,Annie L Conery,Alaa Ahmed,Yat Sun Or,Michael H J Rhodin
BACKGROUND EDP-938 is an oral once-daily RSV nucleoprotein (N) inhibitor with potent antiviral activity. In a human RSV challenge trial, EDP-938 significantly reduced viral load and symptom severity. During antiviral development, it is critical to understand the propensity for resistance to develop. In vitro studies of EDP-938 suggest a higher barrier to resistance as compared to RSV fusion inhibitors
-
Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-23 Bobby L Boyanton,Jane M Caldwell,Nathan A Ledeboer
Pharyngitis is an inflammatory condition of the pharynx and/or tonsils commonly seen in both children and adults. Viruses and bacteria represent the most common encountered etiologic agents-yeast/fungi and parasites are infrequently implicated. Some of these are predominantly observed in unique populations (eg, immunocompromised or unvaccinated individuals). This manuscript (part 2 of 3) summarizes
-
Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-23 Nathan A Ledeboer,Jane M Caldwell,Bobby L Boyanton
Pharyngitis is an inflammatory condition of the pharynx and/or tonsils commonly seen in both children and adults. Viruses and bacteria represent the most common encountered etiologic agents-yeast/fungi and parasites are infrequently implicated. Some of these are predominantly observed in unique populations (eg, immunocompromised or unvaccinated individuals). This manuscript (part 3 of 3) summarizes
-
Review: Known, Emerging, and Remerging Pharyngitis Pathogens J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-23 Jane M Caldwell, Nathan A Ledeboer, Bobby L Boyanton
Pharyngitis is an inflammatory condition of the pharynx and/or tonsils commonly seen in both children and adults. Viruses and bacteria represent the most common encountered etiologic agents—yeast/fungi and parasites are infrequently implicated. Some of these are predominantly observed in unique populations (eg, immunocompromised or unvaccinated individuals). This article (part 1 of 3) summarizes the
-
Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti–HIV-1 Antibodies J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-23 Marie Høst Pahus, Yu Zheng, Maxine Olefsky, Jesper Damsgaard Gunst, Pablo Tebas, Babafemi Taiwo, Ole S Søgaard, Michael J Peluso, Yolanda Lie, Jacqueline D Reeves, Christos J Petropoulos, Marina Caskey, Katharine J Bar
Background Development of a screening assay for the clinical use of broadly neutralizing antibodies (bnAbs) is a priority for HIV therapy and cure initiatives. Methods We assessed the PhenoSense Monoclonal Antibody Assay (Labcorp-Monogram Biosciences), which is Clinical Laboratory Improvement Amendments (CLIA) validated and has been used prospectively and retrospectively in multiple recent bnAb clinical
-
COVID-19 lineages in a minimally vaccinated island population: Genomic epidemiology of SARS-CoV-2 in Haiti J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-23 Carla N Mavian, Massimiliano S Tagliamonte, Maclean Bassett, Meer Alam, Melanie N Cash, Matt Hitchings, Rigan Louis, Alberto Riva, Kayvan Zainabadi, Marie Marcelle Deschamps, Bernard Liautaud, Vanessa Rouzier, Daniel W Fitzgerald, Jean William Pape, J Glenn Morris, Marco Salemi
We monitored SARS-CoV-2 variants in Haiti from 2020-2023. Despite Haitian COVID-19 travel restrictions and in the setting of a vaccination rate of 2.7%, the timing and lineage evolution of the Haiti epidemic mirrored what was occurring in the rest of the world. Sources for importation of lineages into Haiti were the United States (US), the Dominican Republic (DR), Europe, and Brazil, with exportation
-
Neutralizing Antibody Responses to Chlamydia trachomatis in Women and Associations with Chlamydia Outcomes J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-22 Hong Yu, William M Geisler, Chuanbin Dai, Kanupriya Gupta, Gary Cutter, Robert C Brunham
We assessed neutralizing antibody responses in a well-characterized cohort of 60 women with different Chlamydia trachomatis infection outcomes noted at a treatment visit and 3-month follow-up. We found varying rates of neutralization (inhibition of C. trachomatis) in sera at different dilution levels and varying neutralizing antibody titers across outcomes. Median neutralization rates were significantly
-
Exposure to HIV is associated with altered composition of maternal microchimeric T cells in infants J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-22 Blair Armistead, M Quinn Peters, John Houck, Marc Carlson, Christina Balle, Nolawit Mulugeta, Clive M Gray, Heather B Jaspan, Whitney E Harrington
HIV exposed but uninfected infants (iHEU) display altered immunity and are at increased risk of infection. We previously reported that iHEU have decreased maternal microchimerism (MMc)—maternal cells transferred to the offspring in utero/during breastfeeding. We quantified MMc in T cell subpopulations in iHEU and unexposed infants (iHU) to determine whether a selective deficiency in MMc contributes
-
Genomics should inform appropriate analysis of taxonomy and pathogenesis of Rickettsia. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-21 J Stephen Dumler,David H Walker
-
Rickettsia rickettsii subsp. californica subsp. nov., the etiologic agent of Pacific Coast tick fever J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-21 Christopher D Paddock, Sandor E Karpathy, Asa Henry, Luke Ryle, Joy A Hecht, Jill K Hacker, Kerry A Padgett, Anne M Kjemtrup, Hannah Bullock, Robert S Lane, Jason T Ladner
The etiologic agent of Pacific Coast tick fever (PCTF), a moderately severe tickborne illness that resembles Rocky Mountain spotted fever (RMSF), was first isolated in 1966 from specimens of Dermacentor occidentalis (the Pacific Coast tick) obtained in California. For several decades, this bacterium was identified ambiguously as the unclassified spotted fever group Rickettsia species 364-D, Rickettsia
-
“Pathological Insights into Lassa Virus-Induced Vestibular Dysfunction in Mice: Histopathological Analysis of the Inner Ear Vestibular Apparatus” J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-21 Tomoharu Suzuki, Marina Hosotani Saito, Nantian Lin, Atsushi Tamura, Nadezhda Yun, Takaaki Koma, Junki Maruyama, Slobodan Paessler, Tomoko Makishima
Lassa fever (LF), caused by Lassa virus (LASV) infection, typically leads to mild symptoms in humans, yet some survivors experience audiovestibular problems. Here we present vestibular histopathological insights in our LF model mice. We observed: 1) hemorrhage within the vestibular ganglion and stroma beneath the sensory epithelium, 2) preserved hair cells and supporting cells, 3) LASV antigen presence
-
Systems Vaccinology: Navigating the Future of Personalized Immunity and Next Generation Vaccines J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-19 Serena Maria Dib, Sonia Tandon Wimalasena, Daniel S Graciaa, Nadine Rouphael
Systems vaccinology integrates a range of "omics" technologies to identify key immune signatures and enhance vaccine development. This approach aids in understanding variations in immune responses, driven by genetics, health status, and microbiome. Consequently, systems vaccinology helps pave the way for personalized vaccination strategies, essential for addressing diverse populations.
-
Broadening the Global Mpox Response: A Critical Reflection on Vulnerable Populations. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-18 Yusuff Adebayo Adebisi
-
Vaccines for Global Health: Progress and Challenges. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-18 Jane M Knisely,Emily Erbelding
-
Massage Therapists (Sex Workers) and Mpox in the Philippines. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-18 Dalmacito A Cordero
-
MPXV Infection Stimulates a More Robust and Durable Neutralizing Antibody Response Compared to MVA-BN Vaccination J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-18 Christopher N Selverian, Stephanie R Monticelli, Yakin M Jaleta, Gorka Lasso, Megan E DeMouth, Annalisa Meola, Jacob Berrigan, Thomas G Batchelor, Leandro Battini, Pablo Guardado-Calvo, Andrew S Herbert, Kartik Chandran, Eric Meyerowitz, Emily Happy Miller
Monkeypox virus (MPXV) has recently caused a global disease outbreak in humans. Differences in the neutralizing antibody response to vaccination vs. MPXV infection remain poorly understood. Here, we examined the neutralization of MPXV and VACV by sera from a cohort of convalescent and vaccinated individuals at 1- and 8-months post-exposure. Convalescent individuals displayed higher neutralizing antibody
-
Changes in hepatic steatosis before and after direct acting antiviral treatment in people living with HIV and Hepatitis C coinfection. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-17 Esther Truscello,Shouao Wang,Jim Young,Giada Sebastiani,Sharon L Walmsley,Mark Hull,Curtis Cooper,Marina B Klein
BACKGROUND Both HIV and hepatitis C virus (HCV) infection increase the risk of hepatic steatosis (HS), which in turn contributes to the severity and progression of liver disease. Direct acting antivirals (DAAs) can cure HCV but whether they reduce HS is unclear. METHODS HS was assessed using the controlled attenuation parameter (CAP) and the hepatic steatosis index (HSI) in participants coinfected
-
Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-16 Saranathan Rajagopalan, Amy K Rourke, Emmanuel Asare, Donna J Kohlerschmidt, Lahari Das, Senamile L Ngema, Claire V Mulholland, Catherine Vilchèze, Vaishnavi Mahalingam, Sashen Moodley, Barry Truebody, Jared Mackenzie, Adrie J C Steyn, Rubeshan Perumal, Michael Berney, Michelle H Larsen, Max R O’Donnell, Vincent E Escuyer, William R Jacobs
Background Drug-resistant tuberculosis is a growing public health threat, and early characterization of the resistance phenotype is essential for guiding treatment and mitigating the high mortality associated with the disease. However, the slow growth rate of Mycobacterium tuberculosis, the causative agent of tuberculosis, necessitates several weeks for conventional culture-dependent drug susceptibility
-
Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-16 Tara M Babu, Lisa A Jackson, Hana M El Sahly
The development of SARS-CoV-2 next-generation vaccines with the potential for increased effectiveness, durability, breadth, and ability to decrease transmission are of public health importance. We highlight alternative routes of administration of next-generation SARS-CoV-2 vaccines such as mucosal and intradermal administration.
-
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-16 Isabel Leroux-Roels,Cathy Maes,Francesca Mancini,Bart Jacobs,Eleanna Sarakinou,Azhar Alhatemi,Jasper Joye,Silvia Grappi,Giulia Luna Cilio,Alimamy Serry-Bangura,Claudia G Vitali,Pietro Ferruzzi,Elisa Marchetti,Francesca Necchi,Rino Rappuoli,Iris De Ryck,Jochen Auerbach,Anna M Colucci,Omar Rossi,Valentino Conti,Francesco Berlanda Scorza,Ashwani Kumar Arora,Francesca Micoli,Audino Podda,Usman N Nakakana
BACKGROUND We report data from stage 1 of an ongoing 2-staged, phase 1/2 randomized clinical trial with a 4-component generalized modules for membrane antigens-based vaccine against Shigella sonnei and Shigella flexneri 1b, 2a, and 3a (altSonflex1-2-3; GSK). METHODS Europeans aged 18-50 years (N = 102) were randomized (2:1) to receive 2 injections of altSonflex1-2-3 or placebo at 3- or 6-month interval
-
A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-16 Magda Vergouwe,Jason J Biemond,Karlijn van der Straten,Lisa van Pul,Gius Kerster,Mathieu Claireaux,Judith A Burger,Karel A van Dort,Neeltje A Kootstra,Marcel Jonges,Matthijs R A Welkers,Mette D Hazenberg,Hessel Peters-Sengers,Marit J van Gils,W Joost Wiersinga,Emma Birnie,Godelieve J de Bree,
BACKGROUND The immunological determinants of delayed viral clearance and intrahost viral evolution that drive the development of new pathogenic virus strains in immunocompromised individuals are unknown. Therefore, we longitudinally studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune responses in relation to viral clearance and evolution in immunocompromised individuals
-
Effectiveness of the original monovalent mRNA COVID-19 vaccination series against hospitalization for COVID-19-associated venous thromboembolism. J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-15 David N Hager,Yuwei Zhu,Ine Sohn,William B Stubblefield,Michael B Streiff,Manjusha Gaglani,Jay S Steingrub,Abhijit Duggal,Jamie R Felzer,Mary O'Rourke,Ithan D Peltan,Amira Mohamed,Robin Stiller,Jennifer G Wilson,Nida Qadir,Adit A Ginde,Anne E Zepeski,Christopher Mallow,Adam S Lauring,Nicholas J Johnson,Kevin W Gibbs,Jennie H Kwon,Wesley H Self,
BACKGROUND COVID-19 is a strong risk factor for venous thromboembolism (VTE). Few studies have evaluated the effectiveness of COVID-19 vaccination in preventing hospitalization for COVID-19 with VTE. METHODS Adults hospitalized at 21 sites between March 2021 and October 2022 with symptoms of acute respiratory illness were assessed for COVID-19, completion of the original monovalent mRNA COVID-19 vaccination
-
First Report of a Fatal Septicaemia Case Caused by Vibrio metoecus: A Comprehensive Functional and Genomic Study J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-15 Héctor Carmona-Salido, Sofía López-Solís, José Luis López-Hontangas, Carmen Amaro
Background In recent years, we have witnessed an unprecedented increase in the incidence of vibriosis due to global warming. Vibrio metoecus is a recently described V. cholerae-like species that has not been associated with septicemia death in humans. During follow-up of human vibriosis, we received a blood isolate from a patient with secondary septicemia who died a few hours after admission. Methods
-
Relative Effectiveness and Waning of a Third Dose of mRNA COVID-19 Vaccine in Medicare Beneficiaries Aged 65 Years and Older during the BA.1/BA.2 Omicron Period J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-15 Yun Lu, Kathryn Matuska, Rowan McEvoy, Hector S Izurieta, Jessica Rose Hervol, Mikhail Menis, Arnstein Lindaas, Whitney R Steele, Yoganand Chillarige, Michael Wernecke, Jeffrey A Kelman, Richard A Forshee
Background We assessed the added benefit and waning effectiveness of a third COVID-19 vaccine dose (original formula) for preventing COVID-19-related outcomes. Methods We used Medicare claims data to conduct a retrospective cohort study in U.S. community-dwelling Medicare Fee-for-Service beneficiaries aged ≥65 years during the BA.1/BA.2 Omicron period (December 19, 2021 – March 26, 2022). We estimated
-
Trends, Age-Period-Cohort Effects, and Projections in the Incidence and Mortality of HIV/AIDS among the Elderly in China J. Infect. Dis. (IF 5.0) Pub Date : 2024-10-15 Jinwei Chen, Yikun Chang, Yueqian Wu, Hui Tang, Gonghua Wu, Jie Sun, Pengyu Wang, Yuantao Hao, Wangjian Zhang, Zhicheng Du
Background HIV/AIDS among the elderly presents a new public health challenge in China. We aimed to explore historical trends (2004–2018) and project the future (2019–2030) burden of HIV/AIDS incidence and mortality among the elderly in China. Methods We utilized data from the Data Center of China Public Health Science database on HIV/AIDS incidence and mortality, employing the Bayesian age-period-cohort